Fig 1.
Flowchart of patient selection for the longitudinal analysis.
Table 1.
Baseline characteristics of the source population and included sample.
Table 2.
Changes in glycemic control (HbA1c) from baseline to follow-up: proportions, absolute differences, and paired comparisons.
Table 3.
Relationship between categorical change in glycemic control and the magnitude of individual HbA1c change (baseline to follow-up).
Fig 2.
Changes in glycemic control: HbA1c-based categories and individual absolute variation.
Table 4.
Demographic, clinical, therapeutic, and laboratory factors associated with changes in the proportion of patients with HbA1c ≥ 7% between baseline and follow-up: crude and adjusted GEE regression analyses.
Table 5.
Demographic, clinical, therapeutic, and laboratory factors associated with changes in glycemic control among discordant pairs (HbA1c ≥ 7% to <7% transitions between baseline and follow-up).